JD Health International Inc. (JDHIF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 15.47 means the share price is 15.47 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $15.5B is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerJD Health International Inc. (JDHIF) trades at $4.85. JD Health International Inc. operates a comprehensive online healthcare platform in China, offering a wide range of pharmaceutical and healthcare products along with various online services. Market cap: $15.5B, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for JDHIF: JDHIF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates JDHIF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
JDHIF: 2/2 scored disciplines lean bullish. Dominant signal: Moon AI bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
JD Health International Inc. (JDHIF) Healthcare & Pipeline Overview
JD Health International Inc. stands out in the healthcare sector with its extensive online platform that delivers pharmaceutical products and healthcare services, catering to the growing demand for digital health solutions in China.
What Is the Investment Thesis for JDHIF?
With a market capitalization of $15.5B and a P/E ratio of 15.47, the company demonstrates solid profitability, evidenced by a profit margin of 7.3% and a gross margin of 24.8%. The ongoing digital transformation in healthcare, coupled with increasing consumer demand for online medical services, provides a robust growth trajectory. Key value drivers include the expansion of its online pharmacy network and the introduction of innovative healthcare solutions. The company's ability to scale its operations and enhance service offerings will be critical as it navigates the competitive landscape, particularly against established players like Bayer AG (BAYRY) and Fresenius SE & Co. KGaA (FSNUF). However, potential regulatory changes and market volatility present risks that investors may want to evaluate.
Based on FMP financials and quantitative analysis
JDHIF Key Highlights
Market capitalization of $15.5B reflects strong investor confidence in the company's growth prospects.
- P/E ratio of 15.47 indicates a reasonable valuation relative to its earnings potential.
- Profit margin of 7.3% and gross margin of 24.8% highlight operational efficiency and profitability.
- Employee base of 3,564 supports the company's extensive service offerings and operational capabilities.
- No dividend yield currently, indicating a focus on reinvestment for growth.
Who Are JDHIF's Competitors?
JDHIF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BAYRY Bayer AG | $14.07 | -1.54% | $55.3B | — |
| SDZNY Sandoz Group AG | $81.08 | -2.68% | $35.1B | — |
| OTSKY Otsuka Holdings Co., Ltd. | $37.08 | +0.79% | $39.0B | — |
| FSNUF Fresenius SE & Co. KGaA | $54.35 | 0.00% | $30.6B | — |
| RYLPF Koninklijke Philips N.V. | $25.21 | 0.00% | $24.6B | — |
| SOLV Solventum Corporation | $87.80 | +0.17% | $15.2B | 595-pillar |
| EHC Encompass Health Corporation | $121.04 | -0.40% | $12.0B | 895-pillar |
| FMS Fresenius Medical Care AG & Co. KGaA | $22.23 | -0.45% | $11.9B | 825-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are JDHIF's Key Strengths?
Strong online platform with a diverse range of healthcare products and services.
- Established brand presence through parent company JD.com.
- Innovative solutions enhancing customer engagement and loyalty.
What Are JDHIF's Weaknesses?
Limited international presence compared to global competitors.
- Dependence on the Chinese market for revenue generation.
- No dividend yield may deter income-focused investors.
What Could Drive JDHIF Stock Higher?
Expansion of online pharmacy services projected to increase market share.
- Strong demand for online healthcare services driving revenue growth.
- Continuous innovation in health management solutions enhancing customer engagement.
What Are the Key Risks for JDHIF?
Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.
- Regulatory changes impacting the healthcare industry in China.
- Intense competition from established healthcare companies affecting market position.
- Economic downturns influencing consumer spending on healthcare services.
What Are the Growth Opportunities for JDHIF?
- The company's established infrastructure and brand recognition will enable it to capture a larger market share in this rapidly growing segment.
- Growth opportunity 2: The demand for online healthcare services, including consultations and health management solutions, is expected to grow at a CAGR of 20% through 2027. JD Health's diverse service offerings position it to capitalize on this trend, enhancing customer engagement and loyalty.
- Growth opportunity 3: The genetic testing market in China is anticipated to grow to $10 billion by 2026, driven by increasing consumer awareness and technological advancements. JD Health's investment in genetic testing services can leverage this growth, attracting health-conscious consumers seeking personalized healthcare solutions.
- By enhancing its product range in this category, the company can cater to the growing consumer preference for preventive healthcare.
- Growth opportunity 5: The increasing focus on medical aesthetics and beauty care services represents a lucrative market for JD Health. As consumer spending in this sector continues to rise, the company can expand its service offerings to capture a share of this growing demand.
What Are JDHIF's Competitive Advantages?
- Strong brand recognition as a subsidiary of JD.com.
- Comprehensive online platform offering diverse healthcare services.
- Established infrastructure for efficient product distribution and service delivery.
- Robust customer base with increasing demand for digital health solutions.
- Innovative healthcare solutions that enhance customer engagement.
What Does JDHIF Do?
JD Health International Inc. was founded in 2018 and is headquartered in Beijing, China. As a subsidiary of JD Jiankang Limited, the company has positioned itself as a leader in the online healthcare space, capitalizing on the growing trend of digital health solutions in the People's Republic of China. JD Health operates a multifaceted online platform that provides a variety of pharmaceutical and healthcare products, including over-the-counter (OTC) drugs, prescription medications, medical devices, and health supplements. Additionally, the company offers a range of online healthcare services such as consultations, hospital referrals, health check-ups, genetic testing, and beauty care services. The platform also includes health management solutions and technical services, enhancing its value proposition to consumers. With a workforce of 3,564 employees, JD Health has rapidly grown its market presence, leveraging the robust infrastructure of its parent company, JD.com, to reach a wide customer base across China. The company's commitment to innovation and quality healthcare services positions it favorably within the competitive landscape of the healthcare industry.
What Products and Services Does JDHIF Offer?
- Operate an online healthcare platform in China.
- Provide a wide range of pharmaceutical products, including OTC and prescription drugs.
- Offer medical devices and health supplements through direct selling and online retail.
- Deliver online healthcare services, including consultations and health check-ups.
- Facilitate hospital and doctor referrals for patients.
- Provide genetic testing and beauty care services.
- Offer health management and intelligent healthcare solutions.
How Does JDHIF Make Money?
- Revenue generated through the sale of pharmaceutical and healthcare products.
- Income from online healthcare services, including consultations and referrals.
- Earnings from health management solutions and technical services.
- Direct sales of health supplements and medical devices.
- Advertising and promotional services related to healthcare offerings.
What Industry Does JDHIF Operate In?
The healthcare industry in China is experiencing significant growth, driven by increasing demand for digital health solutions and a rising aging population. The market is projected to expand as consumers increasingly seek convenient access to healthcare services. JD Health International Inc. is well-positioned within this landscape, competing with established firms such as Bayer AG (BAYRY) and Koninklijke Philips N.V. (RYLPF). As telemedicine and online healthcare services gain traction, JD Health's robust online platform and diverse service offerings enhance its competitive edge.
Who Are JDHIF's Key Customers?
- Consumers seeking convenient access to healthcare products and services.
- Patients looking for online consultations and referrals.
- Health-conscious individuals interested in supplements and wellness products.
- Individuals requiring medical check-ups and genetic testing.
- Beauty care consumers seeking aesthetic services.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
- ● Reported in CNY, converted to USD
MoonshotScore History
Recorded daily since 2026-08-23 · 20 snapshots
| 2026-08-23 | 51 |
| 2026-08-27 | 51 |
| 2026-08-31 | 51 |
| 2026-09-04 | 51 |
| 2026-09-08 | 51 |
| 2026-09-11 | 51 |
What changed?
The score has stayed at 51.
Over the same 19 days the stock moved +0.0%.
JD Health International Inc. Financial Trajectory
JD Health International Inc. (JDHIF) reported $6.02B in revenue for Q2 FY2026, reflecting 7.5% growth compared to the prior quarter. The company recorded net income of $506.1M, with diluted EPS of $0.16. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Healthcare company. Across the four most recent quarters, JDHIF averaged $0.13 in diluted EPS.
Company Profile
JD Health International Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Beijing, CN. The company is led by CEO Dong Cao. JDHIF has traded publicly since 2020.
How JD Health International Inc. Is Valued
JD Health International Inc. carries a market capitalization of $15.5B, placing it in the large-cap category.
Key Financial Metrics
Return on equity for JD Health International Inc. stands at 9.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.6%, showing how much profit it generates from its asset base. JDHIF trades at a trailing price-to-earnings ratio of 15.47, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 11.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.72 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.9%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
JD Health International Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.16 places it in the safe zone, indicating low near-term bankruptcy risk.
Earnings Track Record
JD Health International Inc. has missed Wall Street's EPS estimate in 5 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 7.6% below estimates on average.
JDHIF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Strong online platform with a diverse range of healthcare products and services.
- Established brand presence through parent company JD.com.
- Innovative solutions enhancing customer engagement and loyalty.
- Upcoming: Expansion of online pharmacy services projected to increase market share.
Bear Case
- Limited international presence compared to global competitors.
- Dependence on the Chinese market for revenue generation.
- No dividend yield may deter income-focused investors.
- Potential: Regulatory changes impacting the healthcare industry in China.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $6.02B | $506M | $0.16 |
| Q4 FY2025 | $5.60B | $408M | $0.13 |
| Q2 FY2025 | $5.27B | $388M | $0.12 |
| Q4 FY2024 | $4.45B | $317M | $0.10 |
Q2 FY2026 · filed 30 Jun 2026 · Financial Modeling Prep
Based on FMP financials and quantitative analysis · Converted to USD from CNY at today's rate
JDHIF Latest News
No recent news available for JDHIF.
JDHIF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for JDHIF.
Price Targets
Wall Street price target analysis for JDHIF.
JDHIF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for JDHIF; grades run from A+ (80-100) to F (below 30).
Leadership: Cao Dong
CEO
Cao Dong has a robust background in the healthcare and technology sectors. He holds a degree in Business Administration and has extensive experience in managing large teams and operations within the healthcare industry. Prior to leading JD Health, he held various strategic roles in technology-driven healthcare companies, focusing on digital transformation and service innovation.
Track Record: Under Cao Dong's leadership, JD Health has expanded its online healthcare platform significantly, increasing its market share in the competitive landscape. He has been instrumental in driving the company's growth strategy, focusing on innovative healthcare solutions and enhancing customer engagement.
JDHIF OTC Market Information
The OTC Other tier includes companies that trade on the over-the-counter market but do not meet the requirements for higher tiers like NYSE or NASDAQ. This tier often includes smaller companies or those with less stringent reporting requirements, which can affect liquidity and transparency.
- OTC Tier: OTC Other
- Potential lack of liquidity, making it difficult to buy or sell shares quickly.
- Less stringent regulatory oversight compared to companies listed on major exchanges.
- Increased volatility due to lower trading volumes.
- Review the company's financial statements for accuracy and transparency.
- Assess the management team’s track record and experience.
- Monitor industry trends and regulatory changes affecting the healthcare sector.
- Evaluate the competitive landscape and market positioning.
- Verify the company's compliance with OTC market regulations.
- Affiliation with JD.com, a well-established company in the e-commerce sector.
- Transparency in financial reporting and disclosures.
- A growing customer base and increasing market share in the healthcare sector.
JD Health International Inc. Healthcare Stock: Key Questions Answered
Is JDHIF a good stock?
Stock Expert AI does not rate JDHIF buy, sell or hold. JD Health International Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the main risks for JDHIF?
JD Health International Inc. faces several risks, including potential regulatory changes that could impact operations within the Chinese healthcare sector.
What are the key factors to evaluate for JDHIF?
Evaluate JDHIF on fundamentals, analyst consensus, and risk factors. P/E: 15.47x vs the S&P 500's ~20-25x. The company's ability to scale its operations and enhance service offerings will be critical as it navigates the competitive landscape, particularly against established players like Bayer AG (BAYRY) and Fresenius SE & Co. KGaA (FSNUF). Not financial advice.
How frequently does JDHIF data refresh on this page?
JDHIF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 calculations are scheduled daily at 10:15 UTC; the score's own date shows its last successful run.
What has driven JDHIF's recent stock price performance?
JD Health International Inc. (JDHIF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong online platform with a diverse range of healthcare products and services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider JDHIF overvalued or undervalued right now?
JD Health International Inc. (JDHIF) trades at 15.47x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of JDHIF?
Yes, most major brokerages offer fractional shares of JD Health International Inc. (JDHIF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track JDHIF's earnings and financial reports?
JD Health International Inc. (JDHIF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for JDHIF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is subject to change; verify with the latest reports.